Submitted by Anonymous (not verified) on 26 June 2025 - 13:28
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 6, Status: Authorised